Queensland policeman Alisdair had a stroke in his early 40s. He now lives an active life thanks to a novel medical technology. The richness of this life changing innovation tends not to shine through in facts and data, which is where patient stories can support advocacy for access.
Securing reimbursement for an innovative therapy can sometimes feel like trying to sell the future to a room full of sceptics armed with red tape.
You’ve got strong data, impressive outcomes, and a therapy that could genuinely change lives – but translating all that into a “yes” from payers, policymakers, and prescribers? That’s another story.
The missing ingredient in many reimbursement strategies isn’t more data or better PowerPoint slides – the human story makes the numbers matter.
One of the most profoundly effective tools at the heart of this effort is real-world patient stories.
MedTech companies that succeed in building compelling cases for reimbursement and uptake weave clinical trial evidence together with human experiences that embody the difference therapy can make. When done right, real-world stories bridge the gap between data and decision-making, connecting with stakeholders on a human level while bolstering credibility and trust.
Here’s how and why patient stories work and how pharmaceutical and medtech marketers can use them to engage stakeholders and secure the outcomes their products deserve.
Turning data into human impact
In our field, we live and breathe data on efficacy rates, safety profiles, QALYs, and cost-effectiveness ratios. These are essential for making a case to payers, policymakers, and providers. However, data alone rarely convinces stakeholders to change behaviours, allocate budgets, or approve funding.
Real-world stories bring data to life. They make abstract concepts tangible. A survival rate of 82% becomes the story of Sarah, a mother of two from Mudgee NSW, who returned to work and saw her son graduate because of an innovative therapy. A reduction in hospitalisations becomes the story of David, whose quality of life improved to the point where he could return to playing cricket with his grandchildren.
These narratives serve a strategic purpose. When stakeholders see a treatment’s lived impact, it humanises the decision-making process, and the therapy becomes a solution to a real problem that affects real people.
Why real-world stories resonate across stakeholder groups
One of the most striking aspects of patient stories is their universality across different stakeholders.
These stories provide policymakers and payers with evidence of societal value. Therapy that enables patients to return to work or reduces the burden on carers contributes to individual lives, the economy, and the healthcare system as a whole.
For clinicians, patient narratives offer a window into a treatment’s practical, day-to-day benefits. It’s one thing to read about a statistically significant improvement in mobility; it’s another to hear about a patient walking unaided for the first time in years.
For patients and advocacy groups, stories foster hope and trust. They demonstrate what is possible and help build a connection with the brand.
For internal stakeholders, such as sales teams, these stories equip them with powerful tools for conversations with healthcare professionals and decision-makers. They transform product features into relatable benefits, making the sales pitch less about “selling” and more about solving problems.
How to use real-world stories effectively
While the power of real-world stories is undeniable, harnessing that power requires skill and care. Here are some practical considerations:
1. Authenticity is non-negotiable
Patients and stakeholders are highly attuned to inauthenticity. A story that feels contrived or overly polished can backfire, eroding trust rather than building it. Real-world stories should come from genuine patient experiences, with their permission and input.
2. Tie stories to evidence
The most effective patient stories highlight the human impact of therapy while connecting it back to the clinical or economic data that stakeholders rely on for decision-making. This combination of emotion and logic is what ultimately drives action.
3. Respect privacy and sensitivity
Patient privacy must be protected at all times. Work with patients to ensure they’re comfortable with how their stories are used and that they retain input throughout the process.
4. Adapt to the audience
Different stakeholders require different types of stories. For policymakers, focus on systemic impact. For clinicians, highlight functional benefits in a medical context. For patients, emphasise hope and empowerment. Tailor the narrative to the priorities of your audience.
5. Make it part of a broader strategy
Stories should be part of an integrated strategy combining qualitative narratives with quantitative data and other tools such as advisory boards, stakeholder engagement activities, and targeted communications.
We recently collaborated with a healthcare organisation to identify a key patient story for one of our rare disease clients, who demonstrated high levels of patient engagement. Despite dealing with a rare disease and experiencing a significant disease burden, his clinicians in his state were unable to provide him with optimised treatment without transferring him out of state. This move would incur personal costs for him to receive proper treatment and alleviate his symptoms.
We used this video at key congresses to build an army of advocates, helping clinicians understand that patients should not face these challenges. With a few smart decisions and collaboration with Pharm, we can support hospitals to have this treatment in the community today.
“You’ve done an outstanding job. It’s very confronting but extremely moving. Let’s hope it’s effective in ‘moving’ physicians to action! Thank you for your sensitivity and professionalism whilst in our home and with the final production.” Quote from the Patient
Brand managers must find those stories, tell them authentically, and use them to stratify demonically. One right, they can be the difference between a therapy that languishes in obscurity and one that transforms lives.
Focus on themes – the real ones. When it comes to engaging stakeholders and securing investment, it’s the stories that stick.
London Agency: first published 30th January 2025
